Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAPAS-3 trial
ISRCTN69078957Phase 3Completed
- Sponsor
- Medical Research Council
- Start
- May 2010
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of stavudine, abacavir, zidovudine, lamivudine, nevirapine and 1 more in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Medical Research Council. Primary endpoints: Clinical and laboratory adverse events and Pharmacokinetic parameters. Started May 2010; status: completed.
02
Drugs
stavudineabacavirzidovudinelamivudinenevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ISRCTN69078957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN69078957.